Colorectal Cancer, Susceptibility To, 12; Crcs12
Description
Colorectal cancer-12 is an autosomal dominant disorder characterized by a high-penetrance predisposition to the development of colorectal adenomas and carcinomas, with a variable tendency to develop multiple and large tumors. Onset usually occurs before age 40 years. The histologic features of the tumors may be unremarkable (Palles et al., 2013) or show microsatellite instability (MSI) (Elsayed et al., 2015).For a general phenotypic description and a discussion of genetic heterogeneity of colorectal cancer, see {114500}.
Genes related to Colorectal Cancer, Susceptibility To, 12; Crcs12
- POLE
Clinical Features
Phenotypes and symptoms related to Colorectal Cancer, Susceptibility To, 12; Crcs12
- Neoplasm
- Carcinoma
- Colon cancer
- Colorectal polyposis
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Colorectal Cancer, Susceptibility To, 12; Crcs12 Is also known as colorectal cancer, susceptibility to, on chromosome 12q24.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Colorectal Cancer, Susceptibility To, 12; Crcs12 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
VistaSeq Colorectal Cancer Panel.
By Molecular Diagnostic Laboratory University of Alberta (Canada).
BLM, BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDH1, CDKN2A, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, ATM, AXIN2, PMS2, POLD1, POLE , (...)
View the complete list with 1 more genes
Specificity
5 %
Genes
100 % |
myRisk Hereditary Cancer.
By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. (United States).
BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDH1, CDK4, CDKN2A, GREM1, BRIP1, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, NBN, ATM , (...)
View the complete list with 7 more genes
Specificity
4 %
Genes
100 % |
Lynch Syndrome Panel.
By Genetic Services Laboratory University of Chicago (United States).
EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE
Specificity
15 %
Genes
100 % |
Comprehensive Hereditary Cancer Panel.
By Genetic Services Laboratory University of Chicago (United States).
RUNX1, BLM, SDHA, SDHB, SDHC, SDHD, BMPR1A, BRCA1, BRCA2, SRP72, STK11, EPCAM, TERC, TERT, TP53, VHL, IKZF1, SAMD9, SAMD9L, CBL , (...)
View the complete list with 33 more genes
Specificity
2 %
Genes
100 % |
Hereditary Melanoma Sequencing Panel.
By Genetic Services Laboratory University of Chicago (United States).
BRCA1, BRCA2, TP53, WRN, POT1, CDK4, CDKN2A, ACD, MC1R, POLE, BAP1
Specificity
10 %
Genes
100 % |
Hereditary Colorectal Cancer High Risk Panel.
By Genetic Services Laboratory University of Chicago (United States).
EPCAM, APC, MLH1, MSH2, MSH6, MUTYH, PMS2, POLD1, POLE
Specificity
12 %
Genes
100 % |
Colorectal Polyposis Panel.
By Genetic Services Laboratory University of Chicago (United States).
BMPR1A, STK11, BUB1B, GREM1, ENG, APC, SMAD4, MUTYH, AXIN2, POLD1, POLE, PTEN
Specificity
9 %
Genes
100 % |
Comprehensive Hereditary Colorectal Cancer Panel.
By Genetic Services Laboratory University of Chicago (United States).
BMPR1A, STK11, BUB1B, EPCAM, TP53, CDH1, GALNT12, GREM1, ENG, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, AXIN2, PMS2, POLD1, POLE, PTEN
Specificity
5 %
Genes
100 % |
You can get up to 68 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SHASHI-PENA SYNDROME; SHAPNS SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY; SCAN1 HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15 MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY; MSCCA PSEUDOACHONDROPLASIA; PSACH NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY